These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
373 related items for PubMed ID: 23938053
1. Synthesis and biological evaluation of novel benzyl-substituted (S)-phenylalanine derivatives as potent dipeptidyl peptidase 4 inhibitors. Liu Y, Si M, Tang L, Shangguan S, Wu H, Li J, Wu P, Ma X, Liu T, Hu Y. Bioorg Med Chem; 2013 Sep 15; 21(18):5679-87. PubMed ID: 23938053 [Abstract] [Full Text] [Related]
2. Design, synthesis, biological evaluation, and docking studies of (s)-phenylalanine derivatives with a 2-cyanopyrrolidine moiety as potent dipeptidyl peptidase 4 inhibitors. Liu Y, Wu Y, Wu H, Tang L, Wu P, Liu T, Hu Y. Chem Biol Drug Des; 2013 Aug 15; 82(2):140-6. PubMed ID: 23530834 [Abstract] [Full Text] [Related]
6. Design, synthesis, and pharmacological evaluation of highly potent and selective dipeptidyl peptidase-4 inhibitors. Jiang T, Zhou Y, Zhu J, Chen Z, Sun P, Zhang Q, Wang Z, Shao Q, Jiang X, Li B, Wang H, Zhu W, Shen J. Arch Pharm (Weinheim); 2015 Jun 15; 348(6):399-407. PubMed ID: 25871012 [Abstract] [Full Text] [Related]
8. Synthesis and evaluation of thiouracil derivatives as dipeptidyl peptidase IV inhibitors. Sharma M, Singh D, Gupta M. Chem Biol Drug Des; 2013 Feb 15; 81(2):257-64. PubMed ID: 23039850 [Abstract] [Full Text] [Related]
9. Discovering novel α-aminoacyl-containing proline derivatives with potent and selective inhibitory activity against dipeptidyl peptidase IV: design, synthesis, biological evaluation, and molecular modeling. Zhang X, Wang J, Su M, Li Z, Li J, Li J, Liu H. Chem Biol Drug Des; 2012 Dec 15; 80(6):843-52. PubMed ID: 22726613 [Abstract] [Full Text] [Related]
12. Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin. Dong J, Gong Y, Liu J, Chen X, Wen X, Sun H. Bioorg Med Chem; 2014 Feb 15; 22(4):1383-93. PubMed ID: 24457090 [Abstract] [Full Text] [Related]
13. Novel series of 3-amino-N-(4-aryl-1,1-dioxothian-4-yl)butanamides as potent and selective dipeptidyl peptidase IV inhibitors. Nitta A, Fujii H, Sakami S, Satoh M, Nakaki J, Satoh S, Kumagai H, Kawai H. Bioorg Med Chem Lett; 2012 Dec 01; 22(23):7036-40. PubMed ID: 23072865 [Abstract] [Full Text] [Related]
14. Synthesis and biological evaluation of pyrrolidine-2-carbonitrile and 4-fluoropyrrolidine-2-carbonitrile derivatives as dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes. Wang J, Feng Y, Ji X, Deng G, Leng Y, Liu H. Bioorg Med Chem; 2013 Dec 01; 21(23):7418-29. PubMed ID: 24153396 [Abstract] [Full Text] [Related]
17. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor. Tajima A, Yamamoto K, Kozakai A, Okumura-Kitajima L, Mita Y, Kitano K, Jingu S, Nakaike S. Eur J Pharmacol; 2011 Mar 25; 655(1-3):99-107. PubMed ID: 21262219 [Abstract] [Full Text] [Related]
19. Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors. Wu D, Jin F, Lu W, Zhu J, Li C, Wang W, Tang Y, Jiang H, Huang J, Liu G, Li J. Chem Biol Drug Des; 2012 Jun 25; 79(6):897-906. PubMed ID: 22381062 [Abstract] [Full Text] [Related]